InDex Pharmaceuticals Holding AB (publ) 1NP.F Stock
InDex Pharmaceuticals Holding AB (publ) Price Chart
InDex Pharmaceuticals Holding AB (publ) 1NP.F Financial and Trading Overview
Contents
| InDex Pharmaceuticals Holding AB (publ) stock price | 0.02 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.03 EUR |
| Bid | 0.04 EUR x N/A |
| Ask | 0.06 EUR x N/A |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.0078 - 0.09 EUR |
| Volume | 2.9K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 19.46M EUR |
| Beta (5Y Monthly) | 0.214559 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
1NP.F Valuation Measures
| Enterprise Value | 23.54M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
InDex Pharmaceuticals Holding AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.214559 |
| 52-Week Change | -52.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.09 EUR |
| 52 Week Low | 0.0078 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.05 EUR |
1NP.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 532.69M |
| Float | 367M |
| Short Ratio | N/A |
| % Held by Insiders | 35.50% |
| % Held by Institutions | 26.96% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.38% |
| Return on Equity (ttm) | -34.84% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -9141000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 1.04 EUR |
| Current Ratio (mrq) | 9.702 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of InDex Pharmaceuticals Holding AB (publ)
| Country | Germany |
| State | N/A |
| City | Solna |
| Address | Berzelius väg 13 |
| ZIP | 171 65 |
| Phone | 46 8 12 20 38 50 |
| Website | https://www.indexpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences for the treatment of various immunological diseases. InDex Pharmaceuticals Holding AB (publ) was founded in 2000 and is headquartered in Solna, Sweden.
Q&A For InDex Pharmaceuticals Holding AB (publ) Stock
What is a current 1NP.F stock price?
InDex Pharmaceuticals Holding AB (publ) 1NP.F stock price today per share is 0.02 EUR.
How to purchase InDex Pharmaceuticals Holding AB (publ) stock?
You can buy 1NP.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InDex Pharmaceuticals Holding AB (publ)?
The stock symbol or ticker of InDex Pharmaceuticals Holding AB (publ) is 1NP.F.
Which industry does the InDex Pharmaceuticals Holding AB (publ) company belong to?
The InDex Pharmaceuticals Holding AB (publ) industry is Biotechnology.
How many shares does InDex Pharmaceuticals Holding AB (publ) have in circulation?
The max supply of InDex Pharmaceuticals Holding AB (publ) shares is 1.26B.
What is InDex Pharmaceuticals Holding AB (publ) Price to Earnings Ratio (PE Ratio)?
InDex Pharmaceuticals Holding AB (publ) PE Ratio is now.
What was InDex Pharmaceuticals Holding AB (publ) earnings per share over the trailing 12 months (TTM)?
InDex Pharmaceuticals Holding AB (publ) EPS is -0.01 EUR over the trailing 12 months.
Which sector does the InDex Pharmaceuticals Holding AB (publ) company belong to?
The InDex Pharmaceuticals Holding AB (publ) sector is Healthcare.